On Thursday 19 October, the WMGMC is hosting a ‘Future of Cancer Treatment’ event, which will feature discussions on personalised medicine, a way of tailoring treatments and healthcare to individual patients.
The free public event will be held from 18:00 – 21:00 at the Education Centre, Level 1, Queen Elizabeth Hospital Birmingham.
Scientific advances, such as whole genome sequencing and wearable technologies, give scientists and clinicians more valuable data which can help in making better decisions on treatments for an individual.
There will be the opportunity to hear about:
- Personalised medicine, and what it means for you
- What ‘big data’ is, and how the information is used
- How using this approach benefits cancer patients
Refreshments will be provided on a first-come, first-serve basis, and there will also be a variety of information stands to browse.
An expert panel will be on hand to take questions, and a debate will be chaired by Professor Dion Morton, Director of the West Midlands Genomic Medicine Centre (WMGMC)
The WMGMC is one of 13 centres nationwide supporting the 100k Genomes Project, and involves 17 NHS Trusts across the region.
The 100,000 genomes project is pioneering, and aims to improve diagnosis and treatment of rare diseases and cancer by sequencing 100,000 whole genomes – a person’s entire genetic code – from patients with certain rare conditions and their families as well as those with certain cancers.
For full details and to register your place, please visit the website via the link below.
If you would like any further information, please contact Debbie Ringham: